ATE126599T1 - Verfahren zur bestimmung von anti-rns- antikörpern. - Google Patents

Verfahren zur bestimmung von anti-rns- antikörpern.

Info

Publication number
ATE126599T1
ATE126599T1 AT92902145T AT92902145T ATE126599T1 AT E126599 T1 ATE126599 T1 AT E126599T1 AT 92902145 T AT92902145 T AT 92902145T AT 92902145 T AT92902145 T AT 92902145T AT E126599 T1 ATE126599 T1 AT E126599T1
Authority
AT
Austria
Prior art keywords
pct
date sep
sec
determining anti
rns
Prior art date
Application number
AT92902145T
Other languages
English (en)
Inventor
Venrooij Walther Jacobus Van
Rene Antonius Hoet
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE126599T1 publication Critical patent/ATE126599T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92902145T 1991-01-22 1992-01-16 Verfahren zur bestimmung von anti-rns- antikörpern. ATE126599T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91200121 1991-01-22

Publications (1)

Publication Number Publication Date
ATE126599T1 true ATE126599T1 (de) 1995-09-15

Family

ID=8207502

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92902145T ATE126599T1 (de) 1991-01-22 1992-01-16 Verfahren zur bestimmung von anti-rns- antikörpern.

Country Status (15)

Country Link
US (1) US5385824A (de)
EP (1) EP0568554B1 (de)
JP (1) JP3288041B2 (de)
KR (1) KR100244799B1 (de)
AT (1) ATE126599T1 (de)
AU (1) AU658860B2 (de)
CA (1) CA2101166C (de)
DE (1) DE69204157T2 (de)
DK (1) DK0568554T3 (de)
ES (1) ES2078733T3 (de)
FI (1) FI107359B (de)
GR (1) GR3017975T3 (de)
IE (1) IE66750B1 (de)
WO (1) WO1992013276A1 (de)
ZA (1) ZA92389B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576186A (en) * 1994-09-01 1996-11-19 The University Of Kansas Diagnosis and monitoring of rheumatological diseases by detection of anti-EF1-α antibodies
ATE529509T1 (de) * 1997-01-21 2011-11-15 Gen Hospital Corp Selektion von proteinen unter verwendung von rna- protein-fusionen
IL155450A0 (en) * 2000-10-20 2003-11-23 Expression Diagnostics Inc Leukocyte expression profiling
US6905827B2 (en) * 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7235358B2 (en) * 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7026121B1 (en) 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7892745B2 (en) * 2003-04-24 2011-02-22 Xdx, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
WO2006029184A2 (en) * 2004-09-08 2006-03-16 Expression Diagnostics, Inc. Genes useful for diagnosing and monitoring inflammation related disorders
WO2006122295A2 (en) * 2005-05-11 2006-11-16 Expression Diagnostics, Inc. Methods of monitoring functional status of transplants using gene panels
CA2648580A1 (en) * 2006-04-07 2008-05-02 Xdx, Inc. Steroid responsive nucleic acid expression and prediction of disease activity
US7993832B2 (en) * 2006-08-14 2011-08-09 Xdx, Inc. Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
EP2102367A2 (de) * 2006-11-09 2009-09-23 XDX, Inc. Verfahren zur diagnose und überwachung des status von systemischem lupus erythematodes
WO2012068107A2 (en) * 2010-11-17 2012-05-24 University Of Florida Research Foundation, Inc. Autoantibody to rna-protein complex detected by quantitative pcr
US20170044591A1 (en) * 2014-04-24 2017-02-16 Alnylam Pharmaceuticals, Inc. Methods and compositions for detecting anti-drug antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784942A (en) * 1984-11-05 1988-11-15 The Board Of Regents For The University Of Oklahoma Monoclonal antibodies against autoimmune RNA proteins
AU5186890A (en) * 1989-02-27 1990-09-26 Biostar Medical Products, Inc. Method and diagnostic test kit for detection of autoimmune antibody

Also Published As

Publication number Publication date
EP0568554B1 (de) 1995-08-16
FI107359B (fi) 2001-07-13
DE69204157T2 (de) 1996-03-21
AU658860B2 (en) 1995-05-04
JP3288041B2 (ja) 2002-06-04
FI933291L (fi) 1993-08-18
GR3017975T3 (en) 1996-02-29
WO1992013276A1 (en) 1992-08-06
US5385824A (en) 1995-01-31
AU1161592A (en) 1992-08-27
FI933291A0 (fi) 1993-07-21
ES2078733T3 (es) 1995-12-16
CA2101166C (en) 2003-05-20
KR930703612A (ko) 1993-11-30
EP0568554A1 (de) 1993-11-10
DE69204157D1 (de) 1995-09-21
DK0568554T3 (da) 1995-12-04
IE66750B1 (en) 1996-02-07
KR100244799B1 (ko) 2000-03-02
IE920132A1 (en) 1992-07-29
JPH06504620A (ja) 1994-05-26
CA2101166A1 (en) 1992-07-23
ZA92389B (en) 1992-09-30

Similar Documents

Publication Publication Date Title
DE69204157D1 (de) Verfahren zur bestimmung von anti-rns-antikörpern.
DE69110098D1 (de) Teststreifen zur visuellen Bestimmung der Blutglucosekonzentration.
DE59705683D1 (de) IMMUNOLOGISCHES NACHWEISVERFAHREN VON ANTIKÖRPERN, DIE GEGEN GEWEBE-TRANSGLUTAMINASE (tTG) GERICHTET SIND, VERWENDUNG VON tTG ZUR DIAGNOSE UND THERAPIEKONTROLLE SOWIE ORALES PHARMAZEUTISCHES MITTEL ENTHALTEND tTG
ATE269978T1 (de) Verfahren zur bestimmung der prognose eines patienten mit einer neurologischen krankheit
IL149171A0 (en) Elisa for vegf
DE3765310D1 (de) Vorrichtung zur bestimmung von gaspartialdruecken im blut.
DE3786200D1 (de) Diagnostische verfahren zum nachweis von lymphomen bei menschen.
NO890071D0 (no) Nedbrytningsanalyse for kollagen type iii.
DE3767123D1 (de) Verfahren zur bestimmung des haematokrit aus vollblut sowie vorrichtung zur durchfuehrung des verfahrens.
SE9103332L (sv) Metod foer diagnos av blodkoagulationssjukdomar
ATE223051T1 (de) Verfahren zur diagnose gutartiger prostataerkrankungen
DE69510336D1 (de) Verfahren zur diagnose von praeklampsie
AU7260496A (en) A method and diagnostic test kit for use in aiding the diagnosis of fibromyyalgia and chronic fatigue syndrome (CFS)
DE3888998D1 (de) Verfahren zur Bestimmung eines Antikörpers in menschlichen Körperflüssigkeiten.
DE3783966D1 (de) Reagens zur pruefung von periodentalen erkrankungen.
ATE122467T1 (de) Verfahren zur detektion von knochen- und anderen bindegewebeerkrankungen bei menschen und tieren.
DE69018840D1 (de) Verfahren und Vorrichtung zur Bestimmung des mittleren arteriellen Blutdruckes.
DK0764273T3 (da) Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose
DE69214843D1 (de) Verfahren zum nachweis von beschädigungen des magenepithels
ATE173830T1 (de) Verfahren zur bestimmung der quantität extrazellulärer bpi in körperflüssigkeiten
FI874834A7 (fi) Nukleiinihappokoettimet latenttien ihmisen sytomegalovirusten osoittamiseksi verituotteissa.
ATE148233T1 (de) Verfahren zur bestimmung von thrombose verursachenden lupus-anticoagulant-antikörpern
ATA338987A (de) Verfahren zur bestimmung von anti-p.falciparum- sporozoit-antikörpern im menschlichen blut
DE69010926D1 (de) Methode zur Anzeige von Reflexionseigenschaften bei Ultraschalluntersuchungen.
DE69618451D1 (de) Verfahren zur feststellung einer allergie

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee